Bogle Investment Management’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Bogle Investment Management’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-197,855	Closed	-$2.16M	–	532
2016 Q1	$2.16M	Buy	197,855 +131,485	+198%	+$1.66M	0.14%	161
2015 Q4	$1.15M	Sell	66,370 -608,164	-90%	-$10.9M	0.08%	253
2015 Q3	$13.4M	Buy	674,534 +367,749	+120%	+$8.43M	0.95%	6
2015 Q2	$5.04M	Sell	306,785 -47,747	-13%	-$828K	0.38%	99
2015 Q1	$5.52M	Buy	354,532 +134,757	+61%	+$2.09M	0.38%	92
2014 Q4	$3.14M	Buy	+219,775	New	+$2.32M	0.21%	145
2014 Q2	–	Sell	-128,391	Closed	-$917K	–	419
2014 Q1	$917K	Buy	+128,391	New	+$1.1M	0.06%	275
2013 Q4	–	Sell	-122,026	Closed	-$761K	–	394
2013 Q3	$761K	Sell	122,026 -150,994	-55%	-$943K	0.08%	239
2013 Q2	$1.8M	Buy	+273,020	New	+$2.17M	0.22%	144

Other funds holding SCMP

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Bogle Investment Management's SCMP Position: Q2 2016 in Review

Bogle Investment Management sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q2 2016, closing a stake of 197,855 shares — an estimated $2.16M sold.

Bogle Investment Management first reported a position in SCMP in Q2 2013 and held it in 9 quarters. The position peaked at $13.4M in Q3 2015. 136 funds tracked by Wall St. Rank hold SCMP as of Q2 2016.

Bogle Investment Management reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q2 2016 after selling out during the quarter.
Bogle Investment Management sold 197,855 Sucampo Pharmaceuticals, Inc. shares in Q2 2016, an estimated $2.16M.
Bogle Investment Management first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2013 and held it in 9 quarters.
Bogle Investment Management's Sucampo Pharmaceuticals, Inc. position peaked at $13.4M in Q3 2015.
136 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q2 2016.

Based on Bogle Investment Management's 13F filing for Q2 2016, filed 12 Aug 2016.